Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Dixon sequential method for ED50 of oliceridine fumarate + ciprofol in pediatric painless lumbar puncture
ChiCTR2600123626Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Apr 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oliceridine and ciprofol in hematopoietic malignancies, sponsored by Shanghai Children's Medical Center. Primary endpoint: Movement response during lumbar puncture. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
oliceridineciprofol
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ChiCTR2600123626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123626.